[Iatrogenic diabetic coma. Contribution to adverse effects of cytostatic therapy].
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects; D003926:Diabetic Coma / Q000139:chemically induced*; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011241:Prednisone / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate
Iatrogenes diabetisches Koma. Ein Beitrag zu Nebenwirkungern der Zytostatikatherapie.